TORONTO–(BUSINESS WIRE)–Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors. Tilray will use the new funding to increase its existing production capacity in North America, to continue…

Male-to-female transgender workers can see their earnings drop by nearly a third but activists are working to change that The post For transgender women, the pay equity gap is even wider appeared first onMacleans.ca . ▶ Full story on macleans.ca Image source : macleans.ca All copyrights for this article are reserved to the original source…

Supreme Cannabis Co. Inc. (OTCPK:SPRWF), until recently known as Supreme Pharmaceuticals Inc., will compete in the soon to be supremely competitive Canadian marijuana market. The company already produces and sells bulk products out of its Kincardine, Ontario, facility. The Canadian marijuana market was the most exciting market to watch in 2017. The market was full…

February 08, 2018 08:37 ET | Source: Abattis Bioceuticals Corp. VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces that, further to its news release dated February 1, 2018, it has completed its acquisition of a 49% stake in CannaNUMUS Blockchain Inc. (“CannaNUMUS”), pursuant to…

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (EMH.V) (“Emerald” or the “Company”) has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed,…